Markus Warmuth is President & CEO of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 544,538 shares of GLUE, which is worth approximately $3.26 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 128,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 545K
n/a 3M change
n/a 12M change
Total Value Held $3.26 Million

Markus Warmuth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
128,000 Added 19.03%
544,538 Common Stock
MW

Markus Warmuth

President & CEO
Boston, MA

Track Institutional and Insider Activities on GLUE

Follow Monte Rosa Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLUE shares.

Notify only if

Insider Trading

Get notified when an Monte Rosa Therapeutics, Inc. insider buys or sells GLUE shares.

Notify only if

News

Receive news related to Monte Rosa Therapeutics, Inc.

Track Activities on GLUE